Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Laparoscopy | 58 | 2023 | 746 | 18.590 |
Why?
|
Gastroesophageal Reflux | 22 | 2023 | 117 | 14.240 |
Why?
|
Esophageal Achalasia | 25 | 2023 | 57 | 11.760 |
Why?
|
Deglutition Disorders | 15 | 2023 | 115 | 10.060 |
Why?
|
Myotomy | 18 | 2023 | 25 | 8.710 |
Why?
|
Natural Orifice Endoscopic Surgery | 17 | 2023 | 38 | 8.660 |
Why?
|
Hernia, Inguinal | 17 | 2022 | 66 | 8.020 |
Why?
|
Herniorrhaphy | 19 | 2023 | 78 | 7.700 |
Why?
|
Cholecystectomy, Laparoscopic | 13 | 2023 | 50 | 6.580 |
Why?
|
Simulation Training | 11 | 2022 | 88 | 6.150 |
Why?
|
Gastric Bypass | 9 | 2023 | 110 | 5.550 |
Why?
|
Fundoplication | 20 | 2023 | 72 | 5.420 |
Why?
|
Quality of Life | 33 | 2023 | 1575 | 5.210 |
Why?
|
Obesity, Morbid | 12 | 2023 | 219 | 5.190 |
Why?
|
Electric Impedance | 19 | 2023 | 104 | 4.810 |
Why?
|
Treatment Outcome | 77 | 2024 | 7949 | 4.230 |
Why?
|
Hernia, Hiatal | 7 | 2023 | 30 | 3.540 |
Why?
|
Esophagoscopy | 14 | 2023 | 87 | 3.490 |
Why?
|
Curriculum | 12 | 2022 | 537 | 3.330 |
Why?
|
Clinical Competence | 19 | 2022 | 750 | 3.320 |
Why?
|
Esophageal Sphincter, Lower | 15 | 2023 | 32 | 3.310 |
Why?
|
Surgeons | 9 | 2022 | 236 | 3.200 |
Why?
|
Barrett Esophagus | 6 | 2024 | 93 | 3.180 |
Why?
|
Pyloromyotomy | 5 | 2021 | 11 | 3.180 |
Why?
|
Retrospective Studies | 73 | 2024 | 8431 | 3.070 |
Why?
|
Esophagogastric Junction | 7 | 2022 | 34 | 3.020 |
Why?
|
Surgical Mesh | 12 | 2023 | 114 | 2.990 |
Why?
|
Pain, Postoperative | 9 | 2021 | 240 | 2.840 |
Why?
|
Humans | 181 | 2024 | 86281 | 2.820 |
Why?
|
Esophageal Motility Disorders | 4 | 2023 | 12 | 2.800 |
Why?
|
Bariatric Surgery | 6 | 2022 | 194 | 2.670 |
Why?
|
Endoscopy | 15 | 2024 | 331 | 2.600 |
Why?
|
Zenker Diverticulum | 6 | 2023 | 9 | 2.540 |
Why?
|
Internship and Residency | 9 | 2022 | 1001 | 2.500 |
Why?
|
Heller Myotomy | 4 | 2021 | 6 | 2.470 |
Why?
|
Suture Techniques | 7 | 2022 | 134 | 2.290 |
Why?
|
Stomach | 7 | 2023 | 108 | 2.250 |
Why?
|
Education, Medical, Continuing | 5 | 2019 | 107 | 2.220 |
Why?
|
Reoperation | 7 | 2023 | 589 | 2.200 |
Why?
|
Weight Gain | 6 | 2019 | 123 | 2.150 |
Why?
|
Endoscopy, Gastrointestinal | 9 | 2023 | 152 | 2.100 |
Why?
|
Male | 95 | 2024 | 40860 | 2.070 |
Why?
|
Middle Aged | 75 | 2024 | 24957 | 2.060 |
Why?
|
Esophagus | 5 | 2023 | 102 | 1.990 |
Why?
|
Postoperative Complications | 18 | 2020 | 2183 | 1.930 |
Why?
|
Female | 92 | 2024 | 44405 | 1.900 |
Why?
|
Aged | 57 | 2023 | 18353 | 1.850 |
Why?
|
Surgical Stomas | 5 | 2018 | 22 | 1.800 |
Why?
|
Esophageal Neoplasms | 6 | 2019 | 320 | 1.780 |
Why?
|
Operating Rooms | 6 | 2022 | 126 | 1.750 |
Why?
|
Hernia, Abdominal | 4 | 2021 | 14 | 1.720 |
Why?
|
General Surgery | 4 | 2020 | 228 | 1.690 |
Why?
|
Adenocarcinoma | 10 | 2019 | 1160 | 1.660 |
Why?
|
Prospective Studies | 23 | 2023 | 4194 | 1.650 |
Why?
|
Esophagitis, Peptic | 2 | 2022 | 10 | 1.630 |
Why?
|
Incisional Hernia | 5 | 2021 | 17 | 1.610 |
Why?
|
Gastroplasty | 4 | 2024 | 21 | 1.590 |
Why?
|
Choledocholithiasis | 2 | 2023 | 12 | 1.580 |
Why?
|
Gastroparesis | 3 | 2021 | 14 | 1.540 |
Why?
|
Adult | 54 | 2024 | 25577 | 1.460 |
Why?
|
Patient Safety | 5 | 2019 | 212 | 1.450 |
Why?
|
Endoscopy, Digestive System | 3 | 2021 | 65 | 1.390 |
Why?
|
Recurrence | 14 | 2021 | 1137 | 1.380 |
Why?
|
Hospital Costs | 6 | 2016 | 104 | 1.360 |
Why?
|
Intraoperative Complications | 3 | 2022 | 183 | 1.310 |
Why?
|
Education, Medical, Graduate | 4 | 2019 | 368 | 1.230 |
Why?
|
Hospital Charges | 2 | 2020 | 29 | 1.210 |
Why?
|
Disposable Equipment | 3 | 2016 | 18 | 1.210 |
Why?
|
Cholecystitis | 2 | 2020 | 15 | 1.180 |
Why?
|
Jejunum | 3 | 2016 | 78 | 1.180 |
Why?
|
Weight Loss | 7 | 2023 | 229 | 1.160 |
Why?
|
Computer Simulation | 7 | 2022 | 1077 | 1.160 |
Why?
|
Cholecystectomy | 3 | 2022 | 18 | 1.150 |
Why?
|
Asymptomatic Diseases | 2 | 2017 | 41 | 1.100 |
Why?
|
Physicians | 4 | 2024 | 672 | 1.090 |
Why?
|
Lymph Node Excision | 4 | 2017 | 211 | 1.060 |
Why?
|
Cysts | 3 | 2014 | 103 | 1.050 |
Why?
|
Pancreatic Neoplasms | 14 | 2011 | 645 | 1.030 |
Why?
|
Follow-Up Studies | 17 | 2022 | 3616 | 0.980 |
Why?
|
Laparotomy | 3 | 2019 | 59 | 0.950 |
Why?
|
Hernia, Ventral | 3 | 2017 | 24 | 0.940 |
Why?
|
Sutures | 2 | 2022 | 51 | 0.930 |
Why?
|
Esophagitis | 1 | 2023 | 42 | 0.930 |
Why?
|
Length of Stay | 10 | 2023 | 697 | 0.920 |
Why?
|
Hernia, Umbilical | 2 | 2021 | 17 | 0.910 |
Why?
|
Common Bile Duct | 2 | 2023 | 19 | 0.860 |
Why?
|
Biological Products | 2 | 2023 | 143 | 0.860 |
Why?
|
Endoscopic Mucosal Resection | 2 | 2020 | 21 | 0.860 |
Why?
|
Hernia | 3 | 2022 | 23 | 0.850 |
Why?
|
Operative Time | 8 | 2020 | 126 | 0.840 |
Why?
|
Virtual Reality | 1 | 2022 | 21 | 0.830 |
Why?
|
Specialties, Surgical | 3 | 2017 | 64 | 0.830 |
Why?
|
Foreign Bodies | 1 | 2022 | 63 | 0.820 |
Why?
|
Safety | 1 | 2021 | 152 | 0.790 |
Why?
|
Stents | 3 | 2022 | 375 | 0.780 |
Why?
|
Abdominal Wall | 2 | 2020 | 30 | 0.770 |
Why?
|
Esophagoplasty | 1 | 2020 | 10 | 0.770 |
Why?
|
Gastrectomy | 2 | 2022 | 68 | 0.770 |
Why?
|
Insufflation | 1 | 2020 | 10 | 0.770 |
Why?
|
Cohort Studies | 12 | 2023 | 2759 | 0.770 |
Why?
|
Jejunostomy | 2 | 2018 | 14 | 0.750 |
Why?
|
Aged, 80 and over | 16 | 2022 | 6481 | 0.740 |
Why?
|
Cholelithiasis | 1 | 2020 | 34 | 0.740 |
Why?
|
Rectus Abdominis | 2 | 2017 | 35 | 0.740 |
Why?
|
Swine | 5 | 2022 | 554 | 0.730 |
Why?
|
Safety Management | 2 | 2018 | 56 | 0.730 |
Why?
|
Surveys and Questionnaires | 10 | 2024 | 2495 | 0.710 |
Why?
|
Gastric Mucosa | 2 | 2020 | 66 | 0.710 |
Why?
|
Attitude of Health Personnel | 3 | 2020 | 636 | 0.710 |
Why?
|
Databases, Factual | 8 | 2021 | 808 | 0.710 |
Why?
|
Obesity | 7 | 2024 | 962 | 0.700 |
Why?
|
Cardia | 1 | 2019 | 5 | 0.700 |
Why?
|
Teaching | 1 | 2020 | 147 | 0.690 |
Why?
|
Fires | 1 | 2019 | 17 | 0.680 |
Why?
|
Hypoglycemia | 1 | 2019 | 106 | 0.680 |
Why?
|
Perception | 1 | 2020 | 167 | 0.670 |
Why?
|
Pancreaticoduodenectomy | 5 | 2018 | 81 | 0.670 |
Why?
|
Urinary Catheterization | 1 | 2018 | 31 | 0.670 |
Why?
|
Pancreatectomy | 5 | 2011 | 148 | 0.660 |
Why?
|
Time Factors | 11 | 2021 | 5198 | 0.660 |
Why?
|
Risk Assessment | 6 | 2019 | 2253 | 0.650 |
Why?
|
Physicians, Primary Care | 1 | 2020 | 104 | 0.650 |
Why?
|
Gastrointestinal Diseases | 1 | 2019 | 145 | 0.650 |
Why?
|
Feasibility Studies | 7 | 2023 | 751 | 0.650 |
Why?
|
Minimally Invasive Surgical Procedures | 6 | 2016 | 234 | 0.650 |
Why?
|
Chronic Pain | 1 | 2020 | 145 | 0.640 |
Why?
|
Pylorus | 5 | 2021 | 14 | 0.640 |
Why?
|
Parathyroid Diseases | 2 | 2008 | 9 | 0.630 |
Why?
|
Gastrointestinal Tract | 1 | 2019 | 191 | 0.620 |
Why?
|
Stomach Neoplasms | 2 | 2020 | 266 | 0.620 |
Why?
|
Prostatic Hyperplasia | 1 | 2018 | 77 | 0.620 |
Why?
|
Gastrostomy | 1 | 2018 | 69 | 0.610 |
Why?
|
Cell Cycle | 5 | 2010 | 502 | 0.610 |
Why?
|
Hospitals, High-Volume | 1 | 2017 | 35 | 0.610 |
Why?
|
Postoperative Care | 2 | 2020 | 220 | 0.600 |
Why?
|
Early Detection of Cancer | 2 | 2019 | 387 | 0.600 |
Why?
|
Referral and Consultation | 1 | 2020 | 326 | 0.600 |
Why?
|
Dexamethasone | 1 | 2018 | 326 | 0.600 |
Why?
|
Thyroid Diseases | 2 | 2008 | 104 | 0.590 |
Why?
|
Muscular Atrophy | 1 | 2017 | 38 | 0.590 |
Why?
|
Laparoscopes | 1 | 2016 | 15 | 0.580 |
Why?
|
Germ-Line Mutation | 1 | 2019 | 329 | 0.580 |
Why?
|
Esophagectomy | 3 | 2017 | 84 | 0.570 |
Why?
|
Diagnostic Imaging | 1 | 2020 | 468 | 0.560 |
Why?
|
Weight Reduction Programs | 1 | 2016 | 13 | 0.560 |
Why?
|
Registries | 3 | 2022 | 702 | 0.560 |
Why?
|
Checklist | 1 | 2016 | 57 | 0.560 |
Why?
|
Vascular Surgical Procedures | 3 | 2015 | 148 | 0.550 |
Why?
|
Catheter Ablation | 4 | 2011 | 233 | 0.550 |
Why?
|
Goals | 1 | 2016 | 67 | 0.550 |
Why?
|
Prostatectomy | 1 | 2019 | 457 | 0.550 |
Why?
|
Disease Progression | 5 | 2020 | 1531 | 0.540 |
Why?
|
Gastroenterology | 1 | 2017 | 134 | 0.540 |
Why?
|
Surgery, Computer-Assisted | 2 | 2014 | 99 | 0.540 |
Why?
|
Proton Pump Inhibitors | 3 | 2023 | 31 | 0.530 |
Why?
|
Patient Outcome Assessment | 2 | 2019 | 83 | 0.530 |
Why?
|
Medical Errors | 1 | 2016 | 115 | 0.530 |
Why?
|
Gastroscopy | 2 | 2019 | 23 | 0.530 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2020 | 508 | 0.530 |
Why?
|
Blood Vessels | 2 | 2015 | 94 | 0.520 |
Why?
|
Ultrasonics | 1 | 2015 | 38 | 0.520 |
Why?
|
Hemostasis, Surgical | 1 | 2015 | 26 | 0.520 |
Why?
|
Cell Proliferation | 6 | 2010 | 1571 | 0.510 |
Why?
|
Manometry | 4 | 2023 | 43 | 0.510 |
Why?
|
Remission, Spontaneous | 1 | 2014 | 53 | 0.500 |
Why?
|
Splenic Diseases | 1 | 2014 | 16 | 0.500 |
Why?
|
Gastrointestinal Hemorrhage | 2 | 2022 | 229 | 0.490 |
Why?
|
Arteries | 2 | 2012 | 174 | 0.490 |
Why?
|
Body Mass Index | 4 | 2020 | 770 | 0.480 |
Why?
|
Apigenin | 3 | 2009 | 7 | 0.480 |
Why?
|
Gallbladder Diseases | 1 | 2013 | 22 | 0.470 |
Why?
|
Neoplasm Staging | 3 | 2017 | 1932 | 0.460 |
Why?
|
Gallstones | 1 | 2012 | 14 | 0.450 |
Why?
|
Gastric Outlet Obstruction | 1 | 2012 | 10 | 0.440 |
Why?
|
Biliary Dyskinesia | 1 | 2012 | 3 | 0.440 |
Why?
|
Bile Ducts | 3 | 2022 | 59 | 0.440 |
Why?
|
Depsipeptides | 3 | 2010 | 29 | 0.430 |
Why?
|
Ischemic Preconditioning | 1 | 2012 | 37 | 0.430 |
Why?
|
Muscle, Smooth | 1 | 2013 | 354 | 0.420 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2022 | 2350 | 0.420 |
Why?
|
Manikins | 1 | 2011 | 41 | 0.410 |
Why?
|
Competency-Based Education | 1 | 2011 | 35 | 0.410 |
Why?
|
Pain Measurement | 3 | 2020 | 321 | 0.410 |
Why?
|
Genetic Predisposition to Disease | 2 | 2022 | 2267 | 0.410 |
Why?
|
Computer-Assisted Instruction | 1 | 2011 | 43 | 0.410 |
Why?
|
Models, Anatomic | 1 | 2011 | 91 | 0.410 |
Why?
|
Patient Readmission | 4 | 2016 | 324 | 0.400 |
Why?
|
Patient-Centered Care | 1 | 2013 | 202 | 0.400 |
Why?
|
Postoperative Period | 3 | 2016 | 303 | 0.380 |
Why?
|
Duodenal Diseases | 1 | 2010 | 24 | 0.380 |
Why?
|
Patient Reported Outcome Measures | 2 | 2022 | 165 | 0.370 |
Why?
|
Esophageal Sphincter, Upper | 2 | 2020 | 5 | 0.370 |
Why?
|
Risk Factors | 7 | 2019 | 5397 | 0.350 |
Why?
|
Video Recording | 3 | 2019 | 190 | 0.330 |
Why?
|
Incidence | 5 | 2017 | 1568 | 0.320 |
Why?
|
Peritoneum | 2 | 2020 | 57 | 0.320 |
Why?
|
G2 Phase | 2 | 2009 | 34 | 0.320 |
Why?
|
Single-Blind Method | 3 | 2019 | 151 | 0.320 |
Why?
|
Recovery of Function | 3 | 2019 | 272 | 0.310 |
Why?
|
Gastric Emptying | 2 | 2021 | 23 | 0.310 |
Why?
|
Preoperative Care | 5 | 2020 | 390 | 0.310 |
Why?
|
Tomography, X-Ray Computed | 8 | 2020 | 2594 | 0.310 |
Why?
|
Mitosis | 2 | 2009 | 151 | 0.310 |
Why?
|
Illinois | 4 | 2016 | 461 | 0.300 |
Why?
|
Young Adult | 6 | 2019 | 5961 | 0.300 |
Why?
|
Peritoneal Dialysis | 2 | 2017 | 32 | 0.290 |
Why?
|
Activities of Daily Living | 2 | 2020 | 202 | 0.290 |
Why?
|
Quality Improvement | 2 | 2021 | 423 | 0.290 |
Why?
|
Catheters, Indwelling | 2 | 2017 | 110 | 0.280 |
Why?
|
Task Performance and Analysis | 2 | 2016 | 86 | 0.280 |
Why?
|
Program Evaluation | 2 | 2019 | 297 | 0.280 |
Why?
|
Intussusception | 1 | 2006 | 16 | 0.280 |
Why?
|
Robotic Surgical Procedures | 2 | 2022 | 264 | 0.280 |
Why?
|
Video-Assisted Surgery | 1 | 2006 | 6 | 0.280 |
Why?
|
Stomach Diseases | 1 | 2006 | 19 | 0.280 |
Why?
|
Pressure | 2 | 2018 | 162 | 0.280 |
Why?
|
Esophageal Diseases | 1 | 2006 | 26 | 0.280 |
Why?
|
Kaplan-Meier Estimate | 3 | 2019 | 859 | 0.280 |
Why?
|
Mesentery | 1 | 2005 | 45 | 0.270 |
Why?
|
Adenocarcinoma, Follicular | 1 | 2006 | 51 | 0.270 |
Why?
|
Educational Measurement | 3 | 2017 | 224 | 0.260 |
Why?
|
Proportional Hazards Models | 2 | 2019 | 857 | 0.260 |
Why?
|
Ischemia | 2 | 2011 | 242 | 0.260 |
Why?
|
Genome-Wide Association Study | 3 | 2022 | 1611 | 0.260 |
Why?
|
Thyroidectomy | 1 | 2006 | 170 | 0.260 |
Why?
|
Prognosis | 3 | 2020 | 3669 | 0.260 |
Why?
|
Equipment Design | 2 | 2016 | 405 | 0.250 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 1 | 2023 | 62 | 0.240 |
Why?
|
Dilatation | 1 | 2023 | 46 | 0.230 |
Why?
|
Anastomosis, Surgical | 3 | 2012 | 264 | 0.230 |
Why?
|
Treatment Failure | 1 | 2023 | 284 | 0.230 |
Why?
|
Magnetic Phenomena | 1 | 2022 | 4 | 0.220 |
Why?
|
Hernia, Diaphragmatic | 1 | 2022 | 10 | 0.220 |
Why?
|
Animals | 8 | 2022 | 26518 | 0.220 |
Why?
|
Bile Duct Diseases | 1 | 2022 | 22 | 0.220 |
Why?
|
Internationality | 2 | 2020 | 69 | 0.220 |
Why?
|
Abdominal Injuries | 1 | 2022 | 39 | 0.220 |
Why?
|
Cost-Benefit Analysis | 3 | 2020 | 450 | 0.220 |
Why?
|
Severity of Illness Index | 3 | 2019 | 1796 | 0.210 |
Why?
|
Vitamin D | 2 | 2015 | 261 | 0.210 |
Why?
|
Kidney Failure, Chronic | 2 | 2017 | 509 | 0.210 |
Why?
|
Self Concept | 2 | 2019 | 133 | 0.210 |
Why?
|
Appendicitis | 1 | 2002 | 62 | 0.200 |
Why?
|
Patient Satisfaction | 2 | 2016 | 452 | 0.200 |
Why?
|
Duodenum | 2 | 2012 | 99 | 0.200 |
Why?
|
Thyroid Neoplasms | 1 | 2006 | 406 | 0.200 |
Why?
|
Esophageal Mucosa | 1 | 2020 | 4 | 0.200 |
Why?
|
User-Computer Interface | 1 | 2022 | 185 | 0.190 |
Why?
|
United States | 8 | 2024 | 6637 | 0.190 |
Why?
|
Age Factors | 3 | 2015 | 1842 | 0.190 |
Why?
|
Intestine, Small | 2 | 2018 | 303 | 0.190 |
Why?
|
Symptom Assessment | 1 | 2020 | 65 | 0.190 |
Why?
|
Dumping Syndrome | 1 | 2019 | 5 | 0.180 |
Why?
|
Urinary Bladder | 1 | 2022 | 236 | 0.180 |
Why?
|
Elective Surgical Procedures | 1 | 2021 | 116 | 0.180 |
Why?
|
Wound Closure Techniques | 1 | 2019 | 14 | 0.180 |
Why?
|
Device Removal | 1 | 2021 | 159 | 0.180 |
Why?
|
DNA Copy Number Variations | 1 | 2020 | 171 | 0.170 |
Why?
|
Catheterization | 2 | 2017 | 232 | 0.170 |
Why?
|
Urinary Retention | 1 | 2018 | 36 | 0.170 |
Why?
|
Adolescent | 5 | 2019 | 8968 | 0.170 |
Why?
|
Cell Cycle Proteins | 4 | 2010 | 388 | 0.170 |
Why?
|
Consensus | 1 | 2020 | 333 | 0.170 |
Why?
|
Hospitals, University | 2 | 2016 | 193 | 0.170 |
Why?
|
Medical Records Systems, Computerized | 1 | 2018 | 40 | 0.160 |
Why?
|
Multivariate Analysis | 2 | 2019 | 997 | 0.160 |
Why?
|
Quality Control | 1 | 2018 | 117 | 0.160 |
Why?
|
Disease Management | 1 | 2020 | 327 | 0.160 |
Why?
|
Suction | 2 | 2008 | 35 | 0.160 |
Why?
|
Visual Analog Scale | 1 | 2017 | 14 | 0.160 |
Why?
|
Aortic Aneurysm, Abdominal | 4 | 2007 | 112 | 0.160 |
Why?
|
Decision Support Systems, Clinical | 1 | 2018 | 103 | 0.150 |
Why?
|
Patient Discharge | 1 | 2020 | 296 | 0.150 |
Why?
|
Crowdsourcing | 1 | 2017 | 12 | 0.150 |
Why?
|
Regional Medical Programs | 1 | 2016 | 5 | 0.150 |
Why?
|
Clinical Audit | 1 | 2016 | 9 | 0.150 |
Why?
|
Dilatation, Pathologic | 1 | 2016 | 54 | 0.150 |
Why?
|
Anastomosis, Roux-en-Y | 1 | 2016 | 26 | 0.150 |
Why?
|
Atrophy | 1 | 2017 | 117 | 0.150 |
Why?
|
Mesenteric Veins | 2 | 2007 | 34 | 0.150 |
Why?
|
Infant, Newborn | 1 | 2022 | 2369 | 0.140 |
Why?
|
Hypotension | 1 | 2017 | 70 | 0.140 |
Why?
|
Primary Health Care | 1 | 2020 | 339 | 0.140 |
Why?
|
Liver Neoplasms | 3 | 2011 | 731 | 0.140 |
Why?
|
Glucocorticoids | 1 | 2018 | 347 | 0.140 |
Why?
|
Cell Line, Tumor | 8 | 2010 | 2421 | 0.140 |
Why?
|
Omentum | 1 | 2016 | 71 | 0.140 |
Why?
|
World Health Organization | 1 | 2016 | 103 | 0.140 |
Why?
|
Japan | 1 | 2016 | 307 | 0.140 |
Why?
|
Blood Vessel Prosthesis Implantation | 3 | 2007 | 208 | 0.140 |
Why?
|
Health Status Indicators | 1 | 2016 | 105 | 0.140 |
Why?
|
Iliac Vein | 2 | 2006 | 30 | 0.130 |
Why?
|
Appendectomy | 1 | 2015 | 32 | 0.130 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2009 | 1958 | 0.130 |
Why?
|
Surgical Instruments | 1 | 2015 | 57 | 0.130 |
Why?
|
Constriction, Pathologic | 3 | 2012 | 212 | 0.130 |
Why?
|
Cost Savings | 1 | 2015 | 66 | 0.130 |
Why?
|
Lymphatic Metastasis | 1 | 2017 | 480 | 0.130 |
Why?
|
Esophageal Spasm, Diffuse | 1 | 2015 | 2 | 0.130 |
Why?
|
Caloric Restriction | 1 | 2015 | 14 | 0.130 |
Why?
|
Logistic Models | 4 | 2015 | 1184 | 0.130 |
Why?
|
Cost Control | 1 | 2015 | 44 | 0.130 |
Why?
|
Antineoplastic Agents | 4 | 2010 | 2351 | 0.130 |
Why?
|
Regional Health Planning | 1 | 2014 | 13 | 0.130 |
Why?
|
Algorithms | 3 | 2018 | 1828 | 0.130 |
Why?
|
Retreatment | 1 | 2015 | 107 | 0.130 |
Why?
|
Abdominal Neoplasms | 1 | 2014 | 39 | 0.130 |
Why?
|
Quality Assurance, Health Care | 1 | 2016 | 220 | 0.130 |
Why?
|
Directive Counseling | 1 | 2015 | 34 | 0.130 |
Why?
|
Hospitalization | 1 | 2020 | 844 | 0.130 |
Why?
|
Chi-Square Distribution | 1 | 2015 | 362 | 0.130 |
Why?
|
Neoplasm Regression, Spontaneous | 1 | 2014 | 7 | 0.130 |
Why?
|
DNA | 1 | 2020 | 1293 | 0.120 |
Why?
|
Palliative Care | 2 | 2007 | 256 | 0.120 |
Why?
|
Image-Guided Biopsy | 1 | 2014 | 65 | 0.120 |
Why?
|
Mucous Membrane | 1 | 2014 | 83 | 0.120 |
Why?
|
Health Status | 1 | 2016 | 360 | 0.120 |
Why?
|
Education, Medical, Undergraduate | 1 | 2016 | 160 | 0.120 |
Why?
|
Subcutaneous Emphysema | 1 | 2013 | 7 | 0.120 |
Why?
|
Bone Density Conservation Agents | 1 | 2014 | 45 | 0.120 |
Why?
|
Watchful Waiting | 1 | 2014 | 60 | 0.120 |
Why?
|
Blood Loss, Surgical | 1 | 2014 | 111 | 0.120 |
Why?
|
Lymph Nodes | 1 | 2017 | 530 | 0.120 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2015 | 231 | 0.120 |
Why?
|
Pancreas | 2 | 2005 | 239 | 0.120 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2008 | 1196 | 0.120 |
Why?
|
Drainage | 1 | 2014 | 157 | 0.120 |
Why?
|
Biomechanical Phenomena | 1 | 2015 | 456 | 0.110 |
Why?
|
Lymphoma | 1 | 2014 | 262 | 0.110 |
Why?
|
Electronic Health Records | 1 | 2016 | 319 | 0.110 |
Why?
|
Chemotherapy, Adjuvant | 2 | 2012 | 468 | 0.110 |
Why?
|
Case-Control Studies | 3 | 2020 | 1801 | 0.110 |
Why?
|
Ligation | 1 | 2012 | 51 | 0.110 |
Why?
|
Intention to Treat Analysis | 1 | 2012 | 72 | 0.110 |
Why?
|
Celiac Artery | 1 | 2012 | 25 | 0.110 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2015 | 427 | 0.110 |
Why?
|
Quality of Health Care | 1 | 2015 | 380 | 0.110 |
Why?
|
Enteral Nutrition | 1 | 2012 | 102 | 0.110 |
Why?
|
Syndrome | 1 | 2012 | 446 | 0.100 |
Why?
|
Patient Simulation | 1 | 2011 | 42 | 0.100 |
Why?
|
United Kingdom | 2 | 2022 | 164 | 0.100 |
Why?
|
Biological Specimen Banks | 2 | 2022 | 64 | 0.100 |
Why?
|
Exercise | 1 | 2015 | 315 | 0.100 |
Why?
|
Diffusion of Innovation | 1 | 2011 | 71 | 0.100 |
Why?
|
Students, Medical | 1 | 2016 | 384 | 0.100 |
Why?
|
Analgesics | 1 | 2012 | 119 | 0.100 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2012 | 291 | 0.100 |
Why?
|
Anastomotic Leak | 1 | 2012 | 96 | 0.100 |
Why?
|
Cyclin A | 2 | 2010 | 28 | 0.100 |
Why?
|
Phosphorylation | 3 | 2010 | 1101 | 0.100 |
Why?
|
Pancreatic Diseases | 1 | 2011 | 52 | 0.100 |
Why?
|
Information Dissemination | 1 | 2011 | 103 | 0.100 |
Why?
|
Sex Factors | 1 | 2014 | 1053 | 0.100 |
Why?
|
Cucumaria | 1 | 2010 | 1 | 0.100 |
Why?
|
Angioplasty | 3 | 2007 | 70 | 0.100 |
Why?
|
Complex Mixtures | 1 | 2010 | 5 | 0.100 |
Why?
|
Down-Regulation | 2 | 2010 | 504 | 0.090 |
Why?
|
Nucleic Acid Synthesis Inhibitors | 2 | 2007 | 15 | 0.090 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2020 | 1305 | 0.090 |
Why?
|
Hepatectomy | 1 | 2011 | 166 | 0.090 |
Why?
|
Necrosis | 1 | 2010 | 204 | 0.090 |
Why?
|
Pneumoperitoneum, Artificial | 1 | 2009 | 7 | 0.090 |
Why?
|
Esophageal pH Monitoring | 1 | 2009 | 12 | 0.090 |
Why?
|
Radiography, Interventional | 1 | 2010 | 150 | 0.090 |
Why?
|
Blotting, Western | 2 | 2009 | 781 | 0.080 |
Why?
|
Flow Cytometry | 2 | 2009 | 679 | 0.080 |
Why?
|
Diagnosis, Differential | 2 | 2014 | 1562 | 0.080 |
Why?
|
Ultrasonography | 2 | 2011 | 695 | 0.080 |
Why?
|
Biocompatible Materials | 1 | 2010 | 193 | 0.080 |
Why?
|
Intestinal Obstruction | 2 | 2011 | 88 | 0.080 |
Why?
|
Models, Animal | 1 | 2009 | 261 | 0.080 |
Why?
|
Probability | 2 | 2009 | 355 | 0.080 |
Why?
|
Prosthesis Implantation | 1 | 2009 | 123 | 0.080 |
Why?
|
Deoxycytidine | 1 | 2009 | 237 | 0.080 |
Why?
|
Embolization, Therapeutic | 1 | 2010 | 238 | 0.080 |
Why?
|
Emergency Medical Services | 1 | 2010 | 209 | 0.080 |
Why?
|
Aortic Rupture | 1 | 2007 | 55 | 0.080 |
Why?
|
Adenocarcinoma, Mucinous | 1 | 2007 | 48 | 0.080 |
Why?
|
Cyclin B | 1 | 2006 | 17 | 0.080 |
Why?
|
Stilbenes | 1 | 2007 | 25 | 0.080 |
Why?
|
cdc25 Phosphatases | 1 | 2006 | 18 | 0.070 |
Why?
|
Parathyroid Hormone | 1 | 2008 | 218 | 0.070 |
Why?
|
Hyperparathyroidism | 1 | 2007 | 67 | 0.070 |
Why?
|
CDC2 Protein Kinase | 1 | 2006 | 45 | 0.070 |
Why?
|
Predictive Value of Tests | 3 | 2011 | 1671 | 0.070 |
Why?
|
Colorectal Neoplasms | 2 | 2011 | 924 | 0.070 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2007 | 108 | 0.070 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2007 | 126 | 0.070 |
Why?
|
Guidelines as Topic | 1 | 2007 | 162 | 0.070 |
Why?
|
Matched-Pair Analysis | 1 | 2006 | 43 | 0.070 |
Why?
|
Carcinoma, Papillary | 1 | 2007 | 158 | 0.070 |
Why?
|
DNA, Neoplasm | 1 | 2006 | 265 | 0.070 |
Why?
|
Neoplasm Seeding | 1 | 2005 | 16 | 0.070 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2009 | 589 | 0.070 |
Why?
|
Cyclooxygenase 2 | 1 | 2005 | 99 | 0.070 |
Why?
|
Tissue Inhibitor of Metalloproteinase-1 | 1 | 2004 | 17 | 0.060 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2007 | 276 | 0.060 |
Why?
|
Flavonoids | 1 | 2005 | 85 | 0.060 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2005 | 211 | 0.060 |
Why?
|
Advance Directives | 1 | 2004 | 64 | 0.060 |
Why?
|
Delphi Technique | 1 | 2024 | 79 | 0.060 |
Why?
|
Peripheral Vascular Diseases | 1 | 2004 | 62 | 0.060 |
Why?
|
Acute Disease | 1 | 2005 | 824 | 0.060 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2004 | 222 | 0.060 |
Why?
|
Survival Analysis | 1 | 2007 | 1536 | 0.060 |
Why?
|
Thrombosis | 1 | 2006 | 296 | 0.060 |
Why?
|
Intestinal Diseases | 1 | 2004 | 79 | 0.060 |
Why?
|
Thrombolytic Therapy | 1 | 2005 | 220 | 0.060 |
Why?
|
Cell Survival | 1 | 2006 | 966 | 0.060 |
Why?
|
Child | 1 | 2014 | 6913 | 0.060 |
Why?
|
Overweight | 1 | 2023 | 118 | 0.050 |
Why?
|
Chronic Disease | 1 | 2005 | 968 | 0.050 |
Why?
|
Judgment | 1 | 2022 | 64 | 0.050 |
Why?
|
Oregon | 2 | 2011 | 26 | 0.050 |
Why?
|
Cell Line | 1 | 2006 | 2466 | 0.050 |
Why?
|
Communication | 1 | 2024 | 438 | 0.050 |
Why?
|
Certification | 1 | 1999 | 58 | 0.040 |
Why?
|
Compliance | 1 | 2018 | 23 | 0.040 |
Why?
|
Physician-Patient Relations | 1 | 2024 | 610 | 0.040 |
Why?
|
Self-Assessment | 1 | 2017 | 47 | 0.040 |
Why?
|
Sensitivity and Specificity | 1 | 2002 | 1987 | 0.040 |
Why?
|
Breast Neoplasms | 1 | 2011 | 2881 | 0.040 |
Why?
|
Equipment Safety | 1 | 2016 | 31 | 0.040 |
Why?
|
Tertiary Care Centers | 1 | 2017 | 93 | 0.040 |
Why?
|
Asia | 1 | 2016 | 94 | 0.040 |
Why?
|
Intraoperative Care | 1 | 2017 | 82 | 0.040 |
Why?
|
Documentation | 1 | 2017 | 98 | 0.040 |
Why?
|
Disease-Free Survival | 2 | 2011 | 1203 | 0.040 |
Why?
|
Monitoring, Intraoperative | 1 | 2017 | 109 | 0.040 |
Why?
|
Fellowships and Scholarships | 1 | 2017 | 107 | 0.040 |
Why?
|
Patient Selection | 2 | 2011 | 685 | 0.030 |
Why?
|
Equipment Failure | 1 | 2016 | 118 | 0.030 |
Why?
|
Hospital Mortality | 1 | 1998 | 347 | 0.030 |
Why?
|
Linear Models | 1 | 2017 | 419 | 0.030 |
Why?
|
Europe | 1 | 2016 | 308 | 0.030 |
Why?
|
Pilot Projects | 1 | 2018 | 837 | 0.030 |
Why?
|
Models, Economic | 1 | 2015 | 60 | 0.030 |
Why?
|
Anesthesia | 1 | 2017 | 163 | 0.030 |
Why?
|
Comorbidity | 2 | 2011 | 943 | 0.030 |
Why?
|
Chest Pain | 1 | 2015 | 42 | 0.030 |
Why?
|
Cell Division | 2 | 2007 | 696 | 0.030 |
Why?
|
Apoptosis | 2 | 2010 | 1678 | 0.030 |
Why?
|
Double-Blind Method | 1 | 2016 | 1822 | 0.030 |
Why?
|
Rats, Sprague-Dawley | 2 | 2005 | 1214 | 0.030 |
Why?
|
Blood Pressure | 1 | 2017 | 1143 | 0.030 |
Why?
|
Ileus | 1 | 2011 | 9 | 0.030 |
Why?
|
Pancreatic Fistula | 1 | 2011 | 16 | 0.020 |
Why?
|
Abdominal Abscess | 1 | 2011 | 22 | 0.020 |
Why?
|
Hospital Departments | 1 | 2010 | 12 | 0.020 |
Why?
|
Annexins | 1 | 2010 | 6 | 0.020 |
Why?
|
Deep Sedation | 1 | 2010 | 15 | 0.020 |
Why?
|
Pancreatitis | 1 | 2011 | 87 | 0.020 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2010 | 59 | 0.020 |
Why?
|
Cyclin-Dependent Kinase 6 | 1 | 2010 | 13 | 0.020 |
Why?
|
Caspase 3 | 1 | 2010 | 159 | 0.020 |
Why?
|
Cyclin E | 1 | 2010 | 27 | 0.020 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2010 | 125 | 0.020 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2010 | 28 | 0.020 |
Why?
|
Cell Growth Processes | 1 | 2010 | 83 | 0.020 |
Why?
|
Spleen | 1 | 2011 | 430 | 0.020 |
Why?
|
Cyclin D1 | 1 | 2010 | 83 | 0.020 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2010 | 74 | 0.020 |
Why?
|
Anesthesia, General | 1 | 2010 | 114 | 0.020 |
Why?
|
S Phase | 1 | 2009 | 62 | 0.020 |
Why?
|
Surgical Wound Infection | 1 | 2011 | 183 | 0.020 |
Why?
|
Neoplasms | 1 | 2004 | 2889 | 0.020 |
Why?
|
Geminin | 1 | 2008 | 1 | 0.020 |
Why?
|
Leupeptins | 1 | 2008 | 21 | 0.020 |
Why?
|
Proteasome Inhibitors | 1 | 2008 | 50 | 0.020 |
Why?
|
Drug Synergism | 1 | 2009 | 303 | 0.020 |
Why?
|
Rats | 2 | 2005 | 3984 | 0.020 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2008 | 99 | 0.020 |
Why?
|
Endarterectomy, Carotid | 2 | 1999 | 73 | 0.020 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2009 | 493 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2009 | 321 | 0.020 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2009 | 236 | 0.020 |
Why?
|
Growth Differentiation Factor 15 | 1 | 2007 | 9 | 0.020 |
Why?
|
Dactinomycin | 1 | 2007 | 35 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2013 | 2699 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2011 | 1680 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2009 | 912 | 0.020 |
Why?
|
Survival Rate | 1 | 2011 | 1856 | 0.020 |
Why?
|
Iliac Artery | 1 | 2006 | 35 | 0.020 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2010 | 380 | 0.020 |
Why?
|
Nitrobenzenes | 1 | 2005 | 11 | 0.020 |
Why?
|
Butadienes | 1 | 2005 | 33 | 0.020 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2005 | 33 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2008 | 937 | 0.020 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2005 | 78 | 0.020 |
Why?
|
Culture Media, Conditioned | 1 | 2005 | 104 | 0.020 |
Why?
|
Coculture Techniques | 1 | 2005 | 164 | 0.020 |
Why?
|
Nitriles | 1 | 2005 | 145 | 0.020 |
Why?
|
Transfection | 1 | 2007 | 895 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2007 | 547 | 0.020 |
Why?
|
Arizona | 1 | 2004 | 10 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2007 | 689 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 2005 | 408 | 0.020 |
Why?
|
Intraoperative Period | 1 | 2004 | 90 | 0.020 |
Why?
|
Up-Regulation | 1 | 2007 | 710 | 0.020 |
Why?
|
Tissue Adhesions | 1 | 2004 | 50 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2008 | 694 | 0.020 |
Why?
|
Sulfonamides | 1 | 2005 | 299 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2008 | 1975 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2007 | 1135 | 0.010 |
Why?
|
Venous Thrombosis | 1 | 2004 | 242 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2005 | 2810 | 0.010 |
Why?
|
California | 1 | 1998 | 138 | 0.010 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 1998 | 66 | 0.010 |
Why?
|
Surgery Department, Hospital | 1 | 1998 | 42 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2004 | 1200 | 0.010 |
Why?
|
Emergencies | 1 | 1998 | 113 | 0.010 |
Why?
|
Quality Indicators, Health Care | 1 | 1998 | 144 | 0.010 |
Why?
|
Coronary Artery Bypass | 1 | 1998 | 228 | 0.010 |
Why?
|
Odds Ratio | 1 | 1998 | 677 | 0.010 |
Why?
|
Signal Transduction | 1 | 2004 | 3233 | 0.010 |
Why?
|